Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Winningham Rick E
Relationship:  
City:   South San Francisco
State:   CA
   
Insider Summary:
  
   
Companies Owned :   3    
Direct Shares   2,686,408    

Indirect Shares

   96,467      
Direct Value   $32,096,465    

Indirect Value

   $926,083      
Total Shares   2,782,875      
Total Value   $33,022,548      


Innoviva Inc $13,189,748 Jazz Pharmaceuticals Inc $1,141,216 Theravance Biopharma, Inc. $17,765,501 Innoviva Inc $13,189,748 Jazz Pharmaceuticals Inc $1,141,216 Theravance Biopharma, Inc. $17,765,501
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    0   
    1    

     Stock price went up :
    0   
    0    
     Stock price went down :
    0   
    1    
   
     Gain/Loss Ratio :
   0.0   
   -1.0   
     Percentage Gain/Loss :
     0.0%
 -15.1%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Innoviva Inc INVA Director 2014-08-15 825,391 2008-01-29 0    Premium*  
            Jazz Pharmaceuticals Inc JAZZ Director 2023-08-14 10,444 2012-01-11 0    Premium*  
            Theravance Biopharma, Inc. TBPH 2024-04-02 1,850,573 2024-04-02 96,467    Premium*  
* Premium Members only  

Records found :    130         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 4 of 6
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
TBPH Theravance Biopharma, Inc... Chief Executive Officer   •       •      –    2015-08-17 4 B $12.13 $204,512 D/D 16,860 602,056 2.81 -
INVA Innoviva Inc Chief Executive Officer   •       •      –    2008-03-11 4 B $10.40 $209,421 D/D 20,000 43,118 2.81 -
INVA Innoviva Inc Chief Executive Officer   •       •      –    2012-05-20 4 D $20.33 $217,145 D/D (10,681) 521,846 0 -
TBPH Theravance Biopharma, Inc... CHIEF EXECUTIVE OFFICER   •       •      –    2022-02-18 4 D $9.61 $218,243 D/D (22,710) 1,279,300 0 -
INVA Innoviva Inc Chief Executive Officer   •       •      –    2013-02-20 4 D $22.10 $235,476 D/D (10,655) 591,922 0 -
TBPH Theravance Biopharma, Inc... Chief Executive Officer   •       •      –    2020-11-20 4 D $17.21 $240,011 D/D (13,946) 1,275,169 0 -
TBPH Theravance Biopharma, Inc... Chief Executive Officer   •       •      –    2017-08-11 4 B $24.50 $245,000 D/D 10,000 866,377 2.81 -
TBPH Theravance Biopharma, Inc... Chief Executive Officer   •       •      –    2020-08-20 4 D $18.22 $254,096 D/D (13,946) 1,289,115 0 -
TBPH Theravance Biopharma, Inc... Chief Executive Officer   •       •      –    2016-11-20 4 D $31.96 $267,186 D/D (8,360) 875,399 0 -
INVA Innoviva Inc Chief Executive Officer   •       •      –    2012-08-20 4 D $27.01 $288,494 D/D (10,681) 580,577 0 -
TBPH Theravance Biopharma, Inc... CHIEF EXECUTIVE OFFICER   •       •      –    2024-02-20 4 D $8.92 $331,788 D/D (37,196) 1,558,769 0 -
INVA Innoviva Inc Chief Executive Officer   •       •      –    2013-08-20 4 D $35.89 $360,551 D/D (10,046) 712,459 0 -
TBPH Theravance Biopharma, Inc... Chief Executive Officer   •       •      –    2019-02-20 4 D $27.00 $363,879 D/D (13,477) 1,099,462 0 -
INVA Innoviva Inc Chief Executive Officer   •       •      –    2013-11-20 4 D $36.40 $365,674 D/D (10,046) 680,060 0 -
INVA Innoviva Inc Chief Executive Officer   •       •      –    2014-02-20 4 D $39.98 $371,694 D/D (9,297) 670,763 0 -
INVA Innoviva Inc Chief Executive Officer   •       •      –    2013-05-20 4 D $37.01 $371,802 D/D (10,046) 711,505 0 -
TBPH Theravance Biopharma, Inc... Chief Executive Officer   •       •      –    2020-05-20 4 D $26.67 $371,940 D/D (13,946) 1,303,061 0 -
TBPH Theravance Biopharma, Inc... Chief Executive Officer   •       •      –    2018-02-20 4 D $29.09 $378,315 D/D (13,005) 881,372 0 -
TBPH Theravance Biopharma, Inc... Chief Executive Officer   •       •      –    2018-11-20 4 D $24.79 $385,658 D/D (15,557) 795,939 0 -
TBPH Theravance Biopharma, Inc... CHIEF EXECUTIVE OFFICER   •       •      –    2023-02-20 4 D $10.44 $390,665 D/D (37,420) 1,313,377 0 -
INVA Innoviva Inc Chief Executive Officer   •       •      –    2012-02-20 4 D $18.54 $396,496 D/D (21,386) 469,302 0 -
INVA Innoviva Inc Chief Executive Officer   •       •      –    2012-05-04 4 OE $3.10 $400,070 D/D 63,225 532,527 0 -
TBPH Theravance Biopharma, Inc... Chief Executive Officer   •       •      –    2018-08-20 4 D $26.95 $419,261 D/D (15,557) 904,063 0 -
INVA Innoviva Inc Chief Executive Officer   •       •      –    2012-08-03 4 OE $3.10 $449,999 D/D 145,161 667,007 0 -
TBPH Theravance Biopharma, Inc... CHIEF EXECUTIVE OFFICER   •       •      –    2022-12-14 4 S $11.19 $559,500 D/D (50,000) 1,350,797 0 %
  130  Records found
  1   2   3   4  5   6      
  Page 4 of 6  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us